We’re making this presentation, first delivered at The Psychedelic Therapeutics and Drug Development conference in New Orleans, available to our Pα+ subscribers. This narrated slide deck, presented by Psychedelic Alpha Founder & Editor Josh Hardman, provides a succinct state of the psychedelics industry before focusing on unanswered questions across psychedelic drug development, clinical rollout, and policy, including:
- Public opinion and political considerations
- Non-traditional access pathways
- Bottlenecks to scaling medicalised delivery
- Wild cards (from IP to public-private partnerships)
- International considerations
- Compass Pathways’ Phase 3 readout
- and more…
This recording is exclusively for our Pα+ subscribers.
Sign-in or join Pα+ to watch this video…
Join Pα+ Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.
Already a member? Log In
✓ Regular Bulletins covering key topics and trends in the psychedelics space
✓ Regular articles and deep dives across psychedelic research, policy and business
✓ Interviews with insiders
✓ Monthly interactive database and commentary on psychedelic patents
✓ Quick-take analysis of major developments
✓ A Library of primers and explainers
✓ Access to our full back catalogue
